Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Novavax COVID-19 vaccine wins belated marketing authorization in Europe

By Brian Buntz | December 20, 2021

NovavaxNovavax (NSDQ:NVAX) has announced that the European Commission has granted it conditional marketing authorization (CMA) for its Nuvaxovid COVID-19 vaccine.

Novavax had received funding early in the pandemic but encountered manufacturing-related delays. In August, the U.S. announced that it was withholding funding from the company over these concerns. The company had initially received $1.7 billion in U.S. funding to develop the vaccine.

The shot is the fifth to win authorization in Europe. The protein-based vaccine will be the first of its kind in Europe.

The World Health Organization (WHO) also won a second Emergency Use Listing (EUL) for the vaccine. In addition, Indonesia and the Philippines have granted the vaccine emergency use authorization.

The news apparently did not impress investors, and NVAX shares fell 7.07% to $201.95.

Early on, Novavax impressed with solid efficacy figures. In March, the company announced that its vaccine was 96.4% effective at preventing COVID-19 caused by wild-type SARS-CoV-2 in a Phase 3 study.

Novavax is partnering with Serum Institute of India (SII) to produce the first doses for the E.U.


Filed Under: Drug Discovery, Infectious Disease
Tagged With: covid-19, Novavax, Nuvaxovid
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Skycovion
European authorities begin review of Skycovion COVID-19 vaccine candidate
Pfizer-BioNTech vaccine
U.S. government plans to stop paying for COVID-19 vaccines 
Monkeypox
U.S. to boost supplies of Tpoxx to fight monkeypox outbreak
Pfizer-BioNTech
Next-gen Pfizer-BioNTech vaccine candidates fare well in Phase 2/3 study

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50